Frontiers of Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2021-05-28 147472eem65暂无昵称

投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间

200 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2022-10-12 ms8000001536521600

投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2021-12-26 ms9000002046803328

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：医学;生物
经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。

175 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2022-02-25 ms5000000841362042

请问这个杂志被拉入黑名单了嘛

134 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2022-04-15 ms1000000867109818

偏重的研究方向：消化疾病;内科
经验分享：这个期刊接受临床预后类文章吗？

176 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2022-07-11 published

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！

126 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2021-07-04 遗忘爱神

偏重的研究方向：肿瘤 ; 医学
经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？

177 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2018-12-24 投稿好磨人

你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表:
我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊

xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊

270 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2018-11-04 xuehui820512_68707702

我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊

245 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=969087, encodeId=a06896908e0f, content=投稿9天了，还是Awaiting Admin Processing，是不是太慢了？有投过的朋友吗，稍微介绍一下大概需要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad065204428, createdName=147472eem65暂无昵称, createdTime=Fri May 28 07:59:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093415, encodeId=03772093415c6, content=投稿时编辑作者过程中出现这个Room/suite，求大神这个空怎么填？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee116144872, createdName=ms8000001536521600, createdTime=Wed Oct 12 16:31:36 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084455, encodeId=61d410844554d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：医学;生物 经验分享：编辑人很好，审的很仔细，意见中肯，人生第一篇，学到了很多东西，没有版面费，感谢主编、编辑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e586425423, createdName=ms9000002046803328, createdTime=Sun Dec 26 19:06:02 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197079, encodeId=c894119e0799a, content=请问这个杂志被拉入黑名单了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf65420959, createdName=ms5000000841362042, createdTime=Fri Feb 25 02:09:03 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211505, encodeId=48201211505f9, content=偏重的研究方向：消化疾病;内科 经验分享：这个期刊接受临床预后类文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Fri Apr 15 18:57:14 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231752, encodeId=72381231e52dd, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：这个杂志还是不错的，未来有发展潜力。请问这个杂志接收后多久能收到proof和online？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41d71636449, createdName=published, createdTime=Mon Jul 11 11:13:37 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996255, encodeId=ed3099625592, content=偏重的研究方向：肿瘤 ; 医学 经验分享：已经Awaiting reviewer assignment快2个月了，他这个状态到底是怎么变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85ba2426608, createdName=遗忘爱神, createdTime=Sun Jul 04 22:58:58 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564818, encodeId=18a5564818bf, content=你好请问现在怎么样啦？我的这个状态有一个多月了xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=xuehui820512_68707702 2018-11-04 11:50:00 发表: 我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/24/4d234c854627f6b332266b7b3d464168.jpg, createdBy=e19c2386851, createdName=投稿好磨人, createdTime=Mon Dec 24 00:00:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562737, encodeId=75ea562e3765, content=我投了快两个月了还显示awaiting reviewer assignment 大家都多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b222103226, createdName=xuehui820512_68707702, createdTime=Sun Nov 04 11:50:00 CST 2018, time=2018-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902783, encodeId=1fb5902e83b0, content=2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1825439058, createdName=鬼混过日子, createdTime=Fri Nov 27 12:44:59 CST 2020, time=2020-11-27, status=1, ipAttribution=)]

2020-11-27 鬼混过日子

2021年估计在4分左右。2022年肯定过6分，这期刊是潜力股。有好文章赶快投。

163 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务